AAV2hAQP1
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AAV2hAQP1, covering 2025-05-22 to 2025-09-25. Get the full timeline:
Most recent: Clinical Trial Update: Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary Hypofunction [Phase 1]